@article{3192254,
    title = "Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV
melanoma: 4-y recurrence-free and overall survival (OS) results from
CheckMate 238",
    author = "Weber, J. and Del Vecchio, M. and Mandala, M. and Gogas, H. and Arance and Fernandez, A. M. and Dalle, S. and Cowey, C. L. and Schenker, M. and and Grob, J-J. and Sileni, V. Chiarion and Marquez-Rodas, I. and Butler, M. and O. and Maio, M. and Middleton, M. and de la Cruz Merino, L. and Lobo, M. and and de Pril, V. and Larkin, J. and Ascierto, P. A.",
    journal = "Annals of Oncology",
    year = "2020",
    volume = "31",
    number = "4",
    pages = "S731-S732",
    publisher = "Elsevier",
    issn = "0923-7534, 1569-8041",
    doi = "10.1016/j.annonc.2020.08.1200"
}